| Literature DB >> 29569501 |
Annette O A Plouvier1, Tim C Olde Hartman1, Anne van Litsenburg1, Bastiaan R Bloem2, Chris van Weel1,3, Antoine L M Lagro-Janssen1.
Abstract
BACKGROUND: Chronically ill patients have to cope with transfers in the level or setting of care. Patients with prevalent disorders such as diabetes mellitus can be supported by their general practitioner (GP) when experiencing such care changes, as the GP already offers them disease-specific care. For community-dwelling patients with low-prevalent diseases such as Parkinson's disease (PD) - for which disease-specific care is provided by medical specialists - tailoring support to handle care changes requires more insight into patients' coping.Entities:
Keywords: Neurology (Parkinson’s disease); general practice/family medicine; patient empowerment; qualitative designs and methods (changes in care)
Mesh:
Year: 2018 PMID: 29569501 PMCID: PMC5917327 DOI: 10.1080/13814788.2018.1447561
Source DB: PubMed Journal: Eur J Gen Pract ISSN: 1381-4788 Impact factor: 1.904
Changes in care named as an example during the visits of the research assistant.
| Change in care |
|---|
| A change in the extent of domestic help that is provided |
Semi-structured interview topic guide (initial version).
| Can you describe the change in care that took place? |
The guide was adapted as the study proceeded; information from the patient’s videos was used to tailor the guide for each interview.
Characteristics of the participating community-dwelling patients with Parkinson’s disease – including oversight of the experienced changes in care.
| Patient Code (A–J) | Sex | Age at start study (years) | Severity of disease at start study: mild–severe (H&Y stage 1–4) | Experienced change(s) in care (each line represents a separate interview and shows the discussed changes in care) | Follow-up period (months) |
|---|---|---|---|---|---|
| A | Male | 65 | 1 | Modification of PD-related pharmacotherapy | 12 |
| B | Female | 58 | 1.5 | Purchase of a tool | 12 |
| C | Male | 59 | 1.5 | Change in unpaid care | 12 |
| D | Male | 76 | 2 | Modification of PD-related pharmacotherapy (adverse effects) | 12 |
| E | Male | 63 | 2 | Purchase of a tool | 12 |
| F | Male | 67 | 1.5 | Acute admission to hospital, modification of PD-related pharmacotherapy | 12 |
| G | Male | 65 | 1.5 | Involvement of a speech therapist | 12 |
| H | Male | 79 | 4 | Acute admission to hospital | 12 |
| I | Female | 75 | 1 | Consultation of GP, planned admission to hospital | 6 |
| J | Male | 73 | 2 | Domestic adjustment, modification of PD-related pharmacotherapy | 6 |
| K | Female | 70 | 4 | Consultation of GP, consultation of neurologist, modification of PD-related pharmacotherapy | 6 |
| L | Male | 72 | 2.5 | 6 | |
| M | Female | 70 | 1 | 6 | |
| N | Female | 64 | 2.5 | Modification of PD-related pharmacotherapy | 6 |
| O | Male | 65 | 1.5 | Consultation of GP, ENT specialist and neurologist, modification of pharmacotherapy (laxative) | 6 |
| P | Male | 72 | 2 | Consultation of neurologist, consultation of GP, modification of pharmacotherapy (laxative) | 6 |
Did not finish follow-up.
Deceased during follow-up.